Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-099203·Caris Life Sciences, Inc.
Schedule 13G ownership disclosure
Caris Life Sciences, Inc.
Common Stock, par value $0.001 per share ("Common Stock"). · CUSIP: 141252107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TSSP Sub-Fund HoldCo, LLC
Shares: 23,166,128.00 · Class: 8.3%
- Alan Waxman
Shares: 24,385,399.00 · Class: 8.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-099203
- Form type
- SCHEDULE 13G
- Filer
- Caris Life Sciences, Inc.
- CIK
- CIK 2019410
- Filed
- Jul 28, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership